Search research articles
Contact Us
Filters
Showing results (71-80 of 89) with videos related to
Page
of 9
Sort By:
Blood
|
August 1, 1990
High-dose etoposide and cyclophosphamide without bone marrow transplantation for resistant hematologic malignancy
R A Brown, R H Herzig, S N Wolff, et al.
The American Journal of Pathology
|
May 1, 1971
Graft-versus-host disease. Morphologic variation and differential diagnosis in 8 cases of HL-A matched bone marrow transplantation
G R Krüger, C W Berard, R A DeLellis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1991
Intensive chemotherapy with cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation for relapsed Hodgkin's disease
D E Reece, M J Barnett, J M Connors, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1989
Allogeneic marrow transplantation for refractory Hodgkin's disease
G L Phillips, D E Reece, M J Barnett, et al.
Cancer
|
May 1, 1982
Veno-occlusive disease of the liver after high-dose mitomycin C therapy and autologous bone marrow transplantation
H M Lazarus, M R Gottfried, R H Herzig, et al.
Bone Marrow Transplantation
|
November 1, 1991
Neurologic complications in allogeneic bone marrow transplant patients receiving cyclosporin
D E Reece, D A Frei-Lahr, J D Shepherd, et al.
British Journal of Haematology
|
January 31, 1998
A randomized phase II study of BB-10010: a variant of human macrophage inflammatory protein-1alpha for patients receiving high-dose etoposide and cyclophosphamide for malignant lymphoma and breast cancer
S H Bernstein, C J Eaves, R Herzig, et al.
The New England Journal of Medicine
|
September 10, 1981
A controlled trial of prophylactic granulocyte transfusions during initial induction chemotherapy for acute myelogenous leukemia
R G Strauss, J E Connett, R P Gale, et al.
Leukemia Research
|
August 24, 1999
Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute myelogenous leukemia in 1st remission
R P Gale, R E Park, R W Dubois, et al.
Leukemia Research
|
October 23, 1998
Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute lymphoblastic leukemia in first remission
R P Gale, R E Park, R W Dubois, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 89) with videos related to
Sort By:
Page
of 9
Blood
|
August 1, 1990
High-dose etoposide and cyclophosphamide without bone marrow transplantation for resistant hematologic malignancy
R A Brown, R H Herzig, S N Wolff, et al.
The American Journal of Pathology
|
May 1, 1971
Graft-versus-host disease. Morphologic variation and differential diagnosis in 8 cases of HL-A matched bone marrow transplantation
G R Krüger, C W Berard, R A DeLellis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1991
Intensive chemotherapy with cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation for relapsed Hodgkin's disease
D E Reece, M J Barnett, J M Connors, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1989
Allogeneic marrow transplantation for refractory Hodgkin's disease
G L Phillips, D E Reece, M J Barnett, et al.
Cancer
|
May 1, 1982
Veno-occlusive disease of the liver after high-dose mitomycin C therapy and autologous bone marrow transplantation
H M Lazarus, M R Gottfried, R H Herzig, et al.
Bone Marrow Transplantation
|
November 1, 1991
Neurologic complications in allogeneic bone marrow transplant patients receiving cyclosporin
D E Reece, D A Frei-Lahr, J D Shepherd, et al.
British Journal of Haematology
|
January 31, 1998
A randomized phase II study of BB-10010: a variant of human macrophage inflammatory protein-1alpha for patients receiving high-dose etoposide and cyclophosphamide for malignant lymphoma and breast cancer
S H Bernstein, C J Eaves, R Herzig, et al.
The New England Journal of Medicine
|
September 10, 1981
A controlled trial of prophylactic granulocyte transfusions during initial induction chemotherapy for acute myelogenous leukemia
R G Strauss, J E Connett, R P Gale, et al.
Leukemia Research
|
August 24, 1999
Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute myelogenous leukemia in 1st remission
R P Gale, R E Park, R W Dubois, et al.
Leukemia Research
|
October 23, 1998
Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute lymphoblastic leukemia in first remission
R P Gale, R E Park, R W Dubois, et al.
Page
of 9